Why the study?
Does daily low-dose aspirin reduce serious perinatal outcomes in pregnant individuals at increased risk for preeclampsia?
Does daily low-dose aspirin reduce serious perinatal outcomes in pregnant individuals at increased risk for preeclampsia?
Daily low-dose aspirin is associated with a reduction in serious perinatal outcomes among pregnant individuals at high risk for preeclampsia, without evident harms.
Answers are grounded in this paper and cite their sources.
Supports low-dose aspirin in high-risk preeclampsia pregnancies; reinforces RCT evidence for perinatal benefit.
Daily low-dose aspirin during pregnancy was associated with lower risks of serious perinatal outcomes for individuals at increased risk for preeclampsia, without evident harms.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: